Early PD signals in people with REM sleep behavior disorder
Official title: A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD
Run by Danish Research Centre for Magnetic Resonance · NCT07790744 · Data updated 2026-11-12
This study tests whether people with REM sleep behavior disorder show early signs of Parkinson’s disease before classic symptoms appear.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Danish Research Centre for Magnetic Resonance Academic / other |
| Locations | 1 site (Hvidovre) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | June 30, 2028 |
| Study ends | December 31, 2035 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT07790744 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with confirmed REM sleep behavior disorder and no major neurological or psychiatric conditions, plus a matched healthy control group.
✕Probably not a fit
Patients with significant comorbidities or implanted devices may not be suitable and may receive limited indirect benefits from broader knowledge.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to deeply characterize early-stage Parkinson’s disease in individuals with REM sleep behavior disorder using multimodal assessments. Participants may undergo advanced imaging and noninvasive evaluations to identify biomarkers and non-motor symptoms that precede motor PD. The research team includes the Danish Research Centre for Magnetic Resonance and collaborators at Danish Sleep Medicine centers, with a focus on understanding prodromal PD trajectories. Enrollment includes adults with verified RBD and age-matched healthy controls, who can provide informed consent. The goal is to improve early detection and inform future interventions for synucleinopathies.
Why it matters
Potential benefit: If successful, the study could improve understanding of early PD markers and guide earlier, more targeted interventions.
How similar studies have gone: Prior work in prodromal PD and RBD cohorts has shown promise in identifying early biomarkers, but this area remains exploratory and evolving.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Both groups - The ability to give informed consent For RBD-group * Verified REM-sleep behaviour disorder via polysonography * No other significant neurological and psychiatric ilness For Healthy controls \- Age matched to RBD-group Exclusion Criteria: * Ferrous objects in or around the body * Pacemaker or other implanted electronic devices * Drug abuse unrelated to medication or alcohol abuse over a period of 6 months prior to the experiment * Other major immunological, cardiac, neurological or neuropsychiatric disorders * Claustrophobia * Incapability of giving informed consent * Unwillingness to be informed about abnormal findings. * Participation in clinical trials involving drug testing over a period of 6 months prior to the experiment. * Disease symptoms leading to excessive movement inside the scanner (e.g., excessive tremor)
Where it's running
-
Danish Research Centre for Magnetic Resonance
Hvidovre, Denmark Recruiting
Study contacts
- Study coordinator: Sune G Thomsen, MD
- Email: sune.gram.thomsen.01@regionh.dk
- Phone: +4552176251
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Increasing physical activity in patients at risk of Parkinson's disease using a smartphone app
This study is testing a smartphone app to help people at risk of Parkinson's disease increase their physical activity and exercise intensity over two years.
-
Automated language analysis to help diagnose neurodegenerative diseases
A multilingual AI-powered language test is being tried to see if speech and language patterns can help differentiate Alzheimer’s, frontotemporal dementia, Lewy body dementia, and Parkinson’s from healthy aging.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Brain alpha-synuclein PET imaging in Parkinson's patients and healthy seniors
This open-label study tests a radioactive tracer called [18F]MK-0947 to see how it behaves in the brains of people with Parkinson's disease compared with healthy elderly volunteers.
-
Parkinson’s self-sufficiency and rehabilitation in a Czech spa setting
This intervention tests whether a Czech self-sufficiency test can be used with people with Parkinson’s disease and sees how spa-based rehabilitation affects independence, cognition, balance, and walking.
-
Imaging PD progression with [18F]AV-133 using high- and standard-resolution PET
This study tests how [18F]AV-133 PET imaging changes over 12 months in people with Parkinson's disease and a small group of healthy controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.